Evidence map›Paper›PMID 39450559›Full record

ArticleMolecular medicine reports2025

Silencing of

Naoki Nanashima, Toshio Norikura, Manabu Nakano, Chie Hata, Kayo Horie

Abstract read
In one paragraph

Article in Molecular medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Naoki NanashimaDepartment of Nutrition, Faculty of Health Science, Aomori University of Health and Welfare, Aomori 030‑8505, Japan.
Toshio NorikuraDepartment of Nutrition, Faculty of Health Science, Aomori University of Health and Welfare, Aomori 030‑8505, Japan.
Manabu NakanoDepartment of Bioscience and Laboratory Medicine, Hirosaki University Graduate School of Health Sciences, Hirosaki, Aomori 036‑8564, Japan.
Chie HataDepartment of Biomedical Data Intelligence, Graduate School of Medicine, Kyoto University, Kyoto 606‑8397, Japan.
Kayo HorieDepartment of Bioscience and Laboratory Medicine, Hirosaki University Graduate School of Health Sciences, Hirosaki, Aomori 036‑8564, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Estrogen‑related receptor (ERR) is an orphan nuclear receptor structurally akin to the estrogen receptor. ERR is expressed in tissues with active energy metabolism and regulates intracellular metabolic functions. Additionally, ERRs are known to be strongly expressed in the epidermis of skin tissue, but their functions are unknown. The present study investigated the function of ERRα in human skin fibroblasts. ERRα expressed in human dermal fibroblast TIG113 was knocked down using small interfering (si)RNA and gene expression was comprehensively analyzed using microarrays 48 h later. Pathway analysis was performed using Wikipathways on genes exhibiting expression changes of ≥1.5‑fold. Expression of cell cycle‑related and apoptosis‑related genes was compared using reverse transcription‑quantitative PCR. After treating TIG113 cells with siERRα for 72 h, cell proliferation was assessed using the Cell Counting Kit‑8 or a scratch wound healing assay and apoptotic cells were measured using the Poly Caspase Assay Kit. Cell cycle analysis was performed using flow cytometry. The expression of the

Indexed as

ApoptosisCell ProliferationERRalpha Estrogen-Related ReceptorFibroblastsReceptors, EstrogenCell CycleCell LineCyclin EGene Expression RegulationGene SilencingHumansRNA, Small InterferingSkinCyclin EERRalpha Estrogen-Related ReceptorReceptors, EstrogenRNA, Small Interferingapoptosiscell proliferationestrogen‑related receptor αskin fibroblast

Identifiers

PMID39450559
PMCPMC11529168

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.